(87 days)
COBE® HVR® 4000TM Filtered Hardshell Venous Reservoir
Not Found
No
The description focuses on the mechanical and material properties of a blood reservoir for cardiopulmonary bypass, with no mention of AI or ML capabilities.
Yes
The device is described as a "venous blood reservoir intended to be used during adult cardiac surgical procedures requiring extracorporeal support," which indicates it is used to treat a condition or restore function for therapeutic purposes during cardiopulmonary bypass.
No
Explanation: The device is a venous reservoir used in cardiopulmonary bypass procedures for blood storage, filtration, and defoaming. Its function is to manage blood flow and volume during surgery, not to diagnose medical conditions.
No
The device description clearly outlines physical components such as a bucket, porting, defoamer, and filter, indicating it is a hardware device used in surgical procedures.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "adult surgical procedures requiring cardiopulmonary bypass." This describes a procedure performed on the patient's body, not a test performed on a sample taken from the patient.
- Device Description: The device is described as a "venous blood reservoir" used during "extracorporeal support." It receives, stores, and filters blood during the bypass procedure. It does not analyze or test the blood for diagnostic purposes.
- Lack of Diagnostic Function: The description focuses on the mechanical functions of the reservoir (receiving, storing, defoaming, filtering) and its role in managing blood volume during bypass. There is no mention of any diagnostic testing or analysis of the blood.
- Performance Studies: The performance studies listed (Defoaming Capability, Operating Volume, Filtration Efficiency, Blood trauma) evaluate the device's ability to handle and process blood during bypass, not its ability to diagnose a condition.
IVD devices are designed to perform tests on samples (like blood, urine, tissue) taken from the human body to provide information for diagnosis, monitoring, or screening. This device's function is entirely within the context of a surgical procedure and managing blood flow during that procedure.
N/A
Intended Use / Indications for Use
The COBE® SMAR T™ HVR® 4000™ Surface Modified Hardshell Venous Reservoirs are intended to be used in adult surgical procedures requiring cardiopulmonary bypass for periods of up to six hours.
Product codes (comma separated list FDA assigned to the subject device)
DTN
Device Description
The COBE® SMAR,T™ HVR® 4000™ Surface Modified Hardshell Venous Reservoirs are sterile devices with non-pyrogenic fluid pathways, for single use only, and are not to be resterilized by the user. The devices are open, hardshell, venous blood reservoirs intended to be used during adult cardiac surgical procedures requiring extracorporeal support for periods of up to six hours. Two configurations are available, one with an integral cardiotomy filter and one without the filter.
The filtered version of the COBE® SMAR.T™ HVR® 4000™ Surface Modified Venous Reservoir, in addition to receiving and storing the patient's venous blood and acting as blood volume buffer, is designed for receiving raw cardiotomy suction blood and filtering it to the circulating blood volume. Entrained air is removed from both the venous blood and cardiotomy suction blood by the defoamer.
The nonfiltered version of the COBE® SMAR,T" HVR® 4000" Surface Modified Venous Reservoir is designed for receiving and storage of the patient's venous blood and acting as blood volume buffer during cardiopulmonary bypass. The defoamer removes air entrained in the venous blood.
The major components of the filtered and nonfiltered COBE® SMAR.T™ HVR® 4000* Surface Modified Hardshell Venous Reservoirs are the bucket, the porting, the defoamer, and in the filtered version, the cardiotomy filter. The bucket serves both as a primary structural component of the device and as a transparent vessel to contain excess blood volume and to allow for the monitoring of changes in blood volume. The porting provides blood tubing connections between the reservoir and the patient, the defoamer serves to remove gross air from incoming venous and cardiotomy suction blood, and the filter removes particles from the cardiotomy suction return blood.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
adult
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance testing consisted of:
-
- Defoaming Capability
-
- Minimum Operating Volume
-
- Maximum Operating Volume
- Filtration Efficiency 4.
-
- Blood trauma: platelet reduction, white blood cell reduction, and plasma free hemoglobin generation
In-vitro testing was performed to demonstrate improved blood compatibility of the materials containing the surface modifying additive and leach testing was conducted to show that the surface modifying additive does not leach from the device.
- Blood trauma: platelet reduction, white blood cell reduction, and plasma free hemoglobin generation
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
COBE® HVR® 4000TM Filtered Hardshell Venous Reservoir
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.4400 Cardiopulmonary bypass blood reservoir.
(a)
Identification. A cardiopulmonary bypass blood reservoir is a device used in conjunction with short-term extracorporeal circulation devices to hold a reserve supply of blood in the bypass circulation.(b)
Classification. Class II (special controls), except that a reservoir that contains a defoamer or filter is classified into the same class as the defoamer or filter. The device, when it is a cardiopulmonary bypass blood reservoir that does not contain defoamers or blood filters, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.
0
510(k) Pre-Market Notification: COBE® SMAR,T™ HVR® 4000™ Surface Modified Venous F
DEC - 3 1999
| 510(k) Summary | |
|---|---|
| SUBMITTER: | COBE Cardiovascular, Inc. |
| 14401 W. 65th Way | |
| Arvada, CO 80004 | |
| CONTACT PERSON: | Lynne Leonard |
| Phone: (303) 467-6586 | |
| Fax: (303) 467-6429 | |
| DATE PREPARED: | September 2, 1999 |
| DEVICE TRADE NAMES: | COBE® SMARxTM HVR® 4000TM Surface Modified Hardshell |
| Venous Reservoir, Filtered | |
| COBE® SMARxTM HVR® 4000TM Surface Modified Hardshell | |
| Venous Reservoir, Nonfiltered | |
| COMMON/USUAL NAMES: | Hardshell Venous Reservoir with Integral Cardiotomy Filter |
| Hardshell Venous Reservoir, Nonfiltered | |
| CLASSIFICATION NAMES: | Cardiopulmonary Bypass Blood Reservoir |
| Cardiopulmonary Bypass Defoamer | |
| Cardiopulmonary Bypass Cardiotomy Suction Line Blood Filter | |
| PREDICATE DEVICE: | COBE® HVR® 4000TM Filtered Hardshell Venous Reservoir |
DEVICE DESCRIPTION:
The COBE® SMAR,T™ HVR® 4000™ Surface Modified Hardshell Venous Reservoirs are sterile devices with non-pyrogenic fluid pathways, for single use only, and are not to be resterilized by the user. The devices are open, hardshell, venous blood reservoirs intended to be used during adult cardiac surgical procedures requiring extracorporeal support for periods of up to six hours. Two configurations are available, one with an integral cardiotomy filter and one without the filter.
The filtered version of the COBE® SMAR.T™ HVR® 4000™ Surface Modified Venous Reservoir, in addition to receiving and storing the patient's venous blood and acting as blood volume buffer, is designed for receiving raw cardiotomy suction blood and filtering it to the circulating blood volume. Entrained air is removed from both the venous blood and cardiotomy suction blood by the defoamer.
The nonfiltered version of the COBE® SMAR,T" HVR® 4000" Surface Modified Venous Reservoir is designed for receiving and storage of the patient's venous blood and acting as blood volume buffer during cardiopulmonary bypass. The defoamer removes air entrained in the venous blood.
The major components of the filtered and nonfiltered COBE® SMAR.T™ HVR® 4000* Surface Modified Hardshell Venous Reservoirs are the bucket, the porting, the defoamer, and in the filtered version, the cardiotomy filter. The bucket serves both as a primary structural component of the device and as a transparent vessel to contain excess blood volume and to allow for the monitoring of changes in blood volume. The porting provides blood tubing connections between the reservoir and the patient, the defoamer serves to remove gross air from incoming venous and cardiotomy suction blood, and the filter removes particles from the cardiotomy suction return blood.
1
INDICATIONS FOR USE
The COBE® SMAR T™ HVR® 4000™ Surface Modified Hardshell Venous Reservoirs are intended to be used in adult surgical procedures requiring cardiopulmonary bypass for periods of up to six hours.
STATEMENT OF TECHNICAL CHARACTERISTICS COMPARISON
The COBE® SMAR, T™ HVR® 4000" Surface Modified Hardshell Venous Reservoirs have the same intended use as the predicate device, the COBE® HVR® 4000™ Fittered Hardshell Venous Reservoir. The primary difference between the COBE® SMAR.T™ HVR® 4000™ Surface Modified Hardshell Venous Reservoirs and the currently marketed COBE® HVR® 4000™ is the COBE® SMAR, T™ HVR® 4000™ Surface Modified Hardshell Venous Reservoirs contain a surface-modifying material which improves the blood compatibility of the device, resulting in reduced platelet adhesion on the treated surfaces.
Biocompatibility and performance tests demonstrate that the COBE® SMAR.T™ HVR® 4000" Surface Modified Hardshell Venous Reservoirs are substantially equivalent to the currently marketed COBE® HVR® 4000™ Filtered Hardshell Venous Reservoir.
Performance testing consisted of:
-
- Defoaming Capability
-
- Minimum Operating Volume
-
- Maximum Operating Volume
- Filtration Efficiency 4.
-
- Blood trauma: platelet reduction, white blood cell reduction, and plasma free hemoglobin generation
In-vitro testing was performed to demonstrate improved blood compatibility of the materials containing the surface modifying additive and leach testing was conducted to show that the surface modifying additive does not leach from the device.
These data support that the COBE® SMAR T™ HVR® 4000™ Surface Modified Hardshell Venous Reservoirs are substantially equivalent to the currently marketed COBE® HVR® 4000™ Filtered Hardshell Venous Reservoir.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Food and Drug Administration
9200 Corporate Boulevard Rockville MD 20850
Image /page/2/Picture/2 description: The image is a black and white circular logo. The logo features a stylized eagle with its wings spread, facing to the left. The eagle is composed of three parallel lines that create the shape of the bird. Encircling the eagle is text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA". The text is arranged around the top and sides of the circle.
DEC -3 1999
Ms. Lynne Leonard Manager, Requlatory Submissions Cobe Cardiovascular, Inc. 14401 West 65th Way Aravada, CO 80004
Re: K993001 COBE® SMAR,T™ HVR® 4000™ Surface Modified Hardshell Venous Regulatory Class:III(3) Product Code: DTN Dated: September 3,1999 Received: September 7,1999
Dear Ms. Leonard:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent for the indications for use stated in the enclosure to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval) it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical General (QS) regulation (21 CFR Part 820) and that, Devices: through periodic QS inspections, FDA will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, the Food and Drug Administration (FDA) may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2 - Ms. Lynne Leonard
This letter will allow you to continue marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4639. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at their toll free number (800) 638-2041 or at (301) 443-6597 or at its internet address
"http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
for Seitz. & Company.
Celia M. Witten, Ph.D., M.D. Acting Director Office of Device Evaluation Center for Devices and Radiological Health
4
Indications For Use
510(k) Number (If known): K993001
Device Names:
COBE® SMAR T™ HVR® 4000™ Surface Modified Hardshell Venous Reservoir, Filtered COBE® SMAR_T™ HVR® 4000" Surface Modified Hardshell Venous Reservoir, Nonfiltered
Indications For Use:
The COBE® SMAR T™ HVR® 4000™ Surface Modified Hardshell Venous Reservoirs are intended to be used in adult surgical procedures requiring cardiopulmonary bypass for periods of up to six hours.
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Cardiovascular, Respiratory, and Neurological Devices
§10(k) Number 1